<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJIM</journal-id><journal-title-group><journal-title>Open Journal of Internal Medicine</journal-title></journal-title-group><issn pub-type="epub">2162-5972</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojim.2021.111002</article-id><article-id pub-id-type="publisher-id">OJIM-107945</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Knowledge and Perceived Barriers towards Intermittent Prevention of Malaria in Pregnancy: A Cross-Sectional Study
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Frank</surname><given-names>Bediako Agyei</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gideon</surname><given-names>Dzando</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Anthony</surname><given-names>B. Donyi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Elisha</surname><given-names>A. Nonoh</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Rebecca</surname><given-names>Dordunu</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Catherine</surname><given-names>Konadu Opoku</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Nursing, Presbyterian University College, Ghana, Abetifi-Kwahu, Ghana</addr-line></aff><aff id="aff2"><addr-line>College of Nursing and Health Sciences, Flinders University, Bedford Park, South Australia, Australia</addr-line></aff><aff id="aff5"><addr-line>University of Ghana Business School, University of Ghana, Legon, Ghana</addr-line></aff><aff id="aff3"><addr-line>Holy Family Nursing and Midwifery Training College, Berekum, Ghana</addr-line></aff><aff id="aff4"><addr-line>School of Nursing and Midwifery, University of Ghana, Legon, Ghana</addr-line></aff><pub-date pub-type="epub"><day>22</day><month>03</month><year>2021</year></pub-date><volume>11</volume><issue>01</issue><fpage>27</fpage><lpage>38</lpage><history><date date-type="received"><day>11,</day>	<month>February</month>	<year>2021</year></date><date date-type="rev-recd"><day>21,</day>	<month>March</month>	<year>2021</year>	</date><date date-type="accepted"><day>24,</day>	<month>March</month>	<year>2021</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background:
   
  Intermittent prevention of malaria is a key strategy adopted globally to ensure the wellbeing of pregnant women. By extension, these strategies enhance the healthy development of the fetus. This study assesses the knowledge and practices of pregnant women towards intermittent malaria 
  prevention strategies in the Juaben Government Hospital of Ghana.
   
  Methods: A cross-sectional
  ,
   quantitative
  ,
   descriptive survey was conducted among 1
  20 pregnant women at the antenatal clinic of the Juaben Government hospital in the Ashanti region of Ghana using a simple random sampling technique in selecting the study participants. The participant response rate was 94.5%. Data w
  ere
   analyzed using Statistical Package for the Social Sciences (SPSS) version 22.0.
   
  Results:
   
  Majority (54.2%) of respondents were between 20
   
  -
   
  29 years of age. Majority of study respondents attended Antenatal visits in their first trimester of pregnancy. Majority (69.2%) have knowledge of malaria preventive strategies in pregnancy, with about 70% of respondents stating these strategies were designed only for pregnant women. Only 37.5% of study respondents could rightly identify the chemoprophylaxis indicated for malaria prevention in pregnancy. Whereas majority (93.3%) of respondents owned insecticide-treated mosquito nets, only 63.3% utilized these nets for their purpose. Barriers to utilization of insecticide-treated nets include difficulty in setting up the nets (26.7%), using mosquito coils (10.8%), and feeling uncomfortable sleeping in the nets (36.7%). Barriers to taking malaria prophylaxis include distance to health facilities (28.3%), thoughts of not being sick with malaria (55.8%), using herbs (10.0%), and not being aware of the essence 
  of prophylaxis (7.5%). Conclusion:
   
  Knowledge of malaria preventive strategies in pregnancy is high. However, utilization of these strategies is low 
  due to perceived human and institutional barriers. A comprehensive community-wide approach is required to improve the utilization of these services among pregnant women.
 
</p></abstract><kwd-group><kwd>Malaria</kwd><kwd> Intermittent Prevention</kwd><kwd> and Treatment (IPTp)</kwd><kwd> Insecticide Treated Nets (ITNs)</kwd><kwd> Antenatal Care</kwd><kwd> Sulphadoxine Pyrimethamine (SP)</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Malaria is an enormous public health problem that affects people of all ages. The World Health Organization (WHO) identifies malaria as a common problem in five regions globally. Sub-Saharan Africa has the largest burden of malarial disease, with over 90% of the world’s malaria-related deaths occurring in this region [<xref ref-type="bibr" rid="scirp.107945-ref1">1</xref>].</p><p>Globally, 125 million women are at risk of malaria in pregnancy and approximately 19.7% of all stillbirths are attributed to malaria in pregnancy [<xref ref-type="bibr" rid="scirp.107945-ref2">2</xref>].</p><p>The World Health Organization estimates that about 219 million cases and 435,000 malaria-related deaths occur globally each year [<xref ref-type="bibr" rid="scirp.107945-ref3">3</xref>]. Acute symptomatic malaria accounts for majority of premature deliveries resulting from maternal anaemia. This in effect disrupts the overall developmental processes of the unborn child [<xref ref-type="bibr" rid="scirp.107945-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.107945-ref5">5</xref>] and threatens the socio-economic fortunes of individuals, families, and their communities at large.</p><p>Malaria is a major cause of illness and death in Ghana, particularly among children and pregnant women. In 2012 for instance, malaria accounted for about 38.8% of all hospital admissions, and 38.9% of all out-patient illnesses [<xref ref-type="bibr" rid="scirp.107945-ref6">6</xref>]. The Ghana Health Service reported in 2015 that malaria is hyperendemic in Ghana and among pregnant women, it accounted for 17.6% of the outpatients’ department (OPD) attendance, 13.7% of admissions and 3.4% of maternal deaths. Malaria in Pregnancy was identified as a major hindrance to the complete attainment of the Millennium Development Goals 4 and 5 in Ghana and had remained a major threat to Sustainable Development Goals 3 and 11.</p><p>The World Health Organization recommends a structured and multi-pronged approach to decrease the burden of malaria infection among pregnant women. These are the use of insecticide-treated nets (ITNs), the use of Intermittent Preventive Treatment (IPT), and effective case management of malaria infection [<xref ref-type="bibr" rid="scirp.107945-ref7">7</xref>]. These three processes are not independent of each other and represent key processes that most countries in Sub-Saharan Africa have embedded into their national health policies to ensure the safety of the mother and the unborn child. Intermittent preventive treatment of malaria in pregnancy (IPTp) is the full therapeutic course of antimalarial medicine given to pregnant women at routine antenatal care visits, regardless of whether the recipient is infected with malaria. The World Health Organization stipulates that intermittent preventive treatment of malaria in pregnancy reduces maternal malaria episodes, maternal and fetal anaemia, placental parasitaemia, low birth weight, and neonatal mortality [<xref ref-type="bibr" rid="scirp.107945-ref8">8</xref>].</p><p>Malaria can be prevented and cured. However, the processes leading to achieving a malaria-free population are costly and limited by the environmental, cultural, and socio-economic conditions of the individuals and communities at risk [<xref ref-type="bibr" rid="scirp.107945-ref9">9</xref>]. Although malaria prevention and treatment services are readily available to pregnant women, the uptake of these services is low in high endemic countries [<xref ref-type="bibr" rid="scirp.107945-ref8">8</xref>]. The preventive and management of malaria in pregnancy require a conscious effort by pregnant women.</p><p>This current study seeks to determine the knowledge and perceived barriers towards intermittent prevention of malaria in pregnancy in the Juaben Government hospital.</p></sec><sec id="s2"><title>2. Materials and Methods</title><p>A descriptive cross-sectional study was carried out among 120 pregnant women who attended antenatal clinics at the Juaben Government Hospital in the Ashanti region of Ghana using a convenient sampling technique. Juaben is a small town in the Ejisu-Juaben municipal district, a district in the Ashanti Region of Ghana. The Juaben hospital is the primary healthcare institution in the municipality. Study participants were randomly selected based on their availability at the time of data collection. Data was collected on the second and fourth Thursdays of June. The second and fourth Thursdays are the main antenatal days in the hospital. Expectant mothers are registered as one of two groups for the main antenatal visits due to their large numbers. Each registrant therefore could only access the main antenatal services ones in every month. The sample size was estimated using Krejcie and Morgan’s (1970) [<xref ref-type="bibr" rid="scirp.107945-ref10">10</xref>] sample size determination table. Accordingly, out of the 190 registrants meant to attend the antenatal clinics on both days, 127 respondents were selected. Seven (7) respondents opted out of the study at various stages of the study. From the sitting arrangement at the clinic, study participants were selected from rows numbered in odd numbers.</p><p>Survey questionnaires were handed out to study participants who could read and write in English. For those participants who could not read and write, questionnaires were read out in English and translated into the local languages and dialects to facilitate data collection. The translation was done by researchers since they were familiar with the local languages and dialects spoken in the municipality. Survey questions were centred on the use of insecticide-treated mosquito nets and the use of chemoprophylaxis, being the recommended strategies in preventing malaria in pregnancy in Ghana. The malaria control program in Ghana recommends that pregnant women must take at least five (5) doses of SP, commencing at the sixteenth week of gestation. In addition to this, free ITNs are distributed to pregnant women at their first antenatal registration as part of the malaria control program. Pregnant women who were not registered or not present at the clinic on the days of data collection were excluded from the study. The instrument for data collection was pretested on 5 pregnant women in Bomfa health centre before the study to ensure validity and reliability.</p><p>Data was validated, coded, and analysed using SPSS Version 22.0. Results were presented in descriptive statistics.</p></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Socio-Demographic Characteristics</title><p>A total of 120 pregnant women were interviewed on two separate antenatal days using a structured pretested questionnaire.</p><p><xref ref-type="table" rid="table1">Table 1</xref> summarizes the socio-demographic characteristics of study participants. From the table, majority (54.2%) of respondents were between ages 20 and 29 years. The rests were either less than 20 years (9.2%) or more than 29 years (36.6%). Majority (73.3%) of study participants were either married or having a partner whiles the rest (26.7%) were either divorced or single. Concerning their educational level, majority (46.7%) had only primary education, 25.8% had secondary education, 11.7 had tertiary education and 15.8% had no form of education. With regards to employment, whiles 17.5% of study participants were unemployed, the majority (82.5%) were either farmers, traders, artisans, or civil servants. The majority (60.0%) of study participants belong to the Akan ethnic group while the rest 40% were either Fantes, Ewes, Gas, or from other minor ethnic groups. Christians dominated the study, forming a (96.0%) majority while the rest (40%) belonged to the Islamic faith. The majority (44.2%) of the women had two children, 15.8% had only one child, 29.2% had three or more children whiles 10.8% were presenting with their first pregnancies. Majority of the study participants were in their first trimester of pregnancy whiles the rest (47.5%) were either in their second or third trimesters. Concerning pre-existing medical conditions, only 5.8% of the women had diabetes and 4.2% had hypertension. The rest 90% had no known pre-existing medical condition.</p></sec><sec id="s3_2"><title>3.2. Knowledge on Intermittent Prevention and Treatment of Malaria</title><p>From <xref ref-type="table" rid="table2">Table 2</xref>, more than half (69.2%) of respondents have heard about IPTp whiles the rest 30.8% had no knowledge on IPTp. The majority (65.8%) of respondents knew the purpose of IPTp, whiles the rest (34.2%) held contrary opinions. Whereas majority (70.0%) believed IPTp-SP was meant for pregnant women, the rest 30% were of the view that the schedule was meant for either infants, the aged, or men. On the drug of choice currently used for IPTp, only 37.5% knew the drug in use. The rest mentioned Chloroquine (26.7%), Artesunate (20.0%), and Quinine (15.8%). Concerning the right time during pregnancy for commencing malaria prophylaxis, 11.7% of study participants did not know when this regimen is commenced, 23.3% chose the first trimester, 18.3% chose the third trimester, and the majority (46.7%) chose the second trimester. Regarding malaria education at Antenatal clinics, a majority (61.7%) attested to malaria education being held at Antenatal clinics whiles 38.3% had a contrary opinion. Regarding the side effects of malaria prophylaxis, whiles 11.7% did not know about any side effects, the rest (88.3%) noted either nausea, vomiting, dizziness, or bodily weakness as some of the side effects.</p></sec><sec id="s3_3"><title>3.3. Barriers to the Use of Intermittent Preventive Strategies</title><p>The majority (93.3%) of respondents personally owned insecticide-treated mosquito nets while (6.7%) did not have any. On the usage, majority (63.3%) attested to using ITNs and 36.7% did not use ITNs. Regarding the reasons for non-usage of ITNs during pregnancy, 26.7% of respondents said they had difficulty setting up the nets, 36.7% said the nets generated too much heat,10.8% preferred to use mosquito coils, 22.5% felt uncomfortable sleeping in the nets and 7.5% were concerned with the chemicals used to treat the nets. Concerning reasons for not taking SP, 46.7% of participants preferred to sleep under ITNs, 55.8% said because they were not sick with malaria, 28.3% attributed non-usage to distance to health facility, 37.5% were afraid of possible side effects, 10.0% preferred to use herbs, 7.5% were unaware of SP. None of the respondents blamed non-usage to unavailability of SP in health facilities. Regarding what motivates participants to complete their SP doses, 80.8% wanted to be directly observed, 90.8% wanted fewer doses, 93.3% said they needed more education, 65.0% said not walking long distance to get SP, 80.8% said they needed a better taste of the medications.</p><table-wrap-group id="1"><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Socio-demographic characteristics of study participants (N = 120)</title></caption><table-wrap id="1_1"><table><tbody><thead><tr><th align="center" valign="middle" >Characteristics</th><th align="center" valign="middle" >Frequency (N)</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Age group</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Below 20</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >9.2</td></tr><tr><td align="center" valign="middle" >20 - 29</td><td align="center" valign="middle" >65</td><td align="center" valign="middle" >54.2</td></tr><tr><td align="center" valign="middle" >30 - 39</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >30.8</td></tr><tr><td align="center" valign="middle" >40 - 49</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >5.8</td></tr><tr><td align="center" valign="middle" >Marital Status</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Single</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >23.3</td></tr><tr><td align="center" valign="middle" >Married/Co-habiting</td><td align="center" valign="middle" >88</td><td align="center" valign="middle" >73.3</td></tr><tr><td align="center" valign="middle" >Divorced</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >3.3</td></tr><tr><td align="center" valign="middle" >Widowed</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Educational level</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >no formal education</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >15.8</td></tr></tbody></table></table-wrap><table-wrap id="1_2"><table><tbody><thead><tr><th align="center" valign="middle" >primary</th><th align="center" valign="middle" >56</th><th align="center" valign="middle" >46.7</th></tr></thead><tr><td align="center" valign="middle" >secondary</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >25.8</td></tr><tr><td align="center" valign="middle" >tertiary</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >11.7</td></tr><tr><td align="center" valign="middle" >Occupation</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Unemployed</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >17.5</td></tr><tr><td align="center" valign="middle" >Farming</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >13.3</td></tr><tr><td align="center" valign="middle" >Trading</td><td align="center" valign="middle" >42</td><td align="center" valign="middle" >35.0</td></tr><tr><td align="center" valign="middle" >Artisanship</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >23.3</td></tr><tr><td align="center" valign="middle" >Civil servant</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >10.8</td></tr><tr><td align="center" valign="middle" >Ethnicity</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Akan</td><td align="center" valign="middle" >72</td><td align="center" valign="middle" >60.0</td></tr><tr><td align="center" valign="middle" >Ewe</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >9.2</td></tr><tr><td align="center" valign="middle" >Ga</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >6.7</td></tr><tr><td align="center" valign="middle" >Fante</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >10.8</td></tr><tr><td align="center" valign="middle" >Other</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >13.3</td></tr><tr><td align="center" valign="middle" >Religion</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Christianity</td><td align="center" valign="middle" >96</td><td align="center" valign="middle" >80.0</td></tr><tr><td align="center" valign="middle" >Islamic</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >20.0</td></tr><tr><td align="center" valign="middle" >Number of children</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >One</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >15.8</td></tr><tr><td align="center" valign="middle" >Two</td><td align="center" valign="middle" >53</td><td align="center" valign="middle" >44.2</td></tr><tr><td align="center" valign="middle" >Three</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >20.0</td></tr><tr><td align="center" valign="middle" >More than three</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >9.2</td></tr><tr><td align="center" valign="middle" >None</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >10.8</td></tr><tr><td align="center" valign="middle" >Trimester of first ANC</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >1st</td><td align="center" valign="middle" >63</td><td align="center" valign="middle" >52.5</td></tr><tr><td align="center" valign="middle" >2nd</td><td align="center" valign="middle" >45</td><td align="center" valign="middle" >37.5</td></tr><tr><td align="center" valign="middle" >3rd</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >10.0</td></tr><tr><td align="center" valign="middle" >Do you have any of these disease</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Diabetes</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >5.8</td></tr><tr><td align="center" valign="middle" >Hypertension</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >4.2</td></tr><tr><td align="center" valign="middle" >Sickle cell disease</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >G6PD</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >None</td><td align="center" valign="middle" >108</td><td align="center" valign="middle" >90.0</td></tr></tbody></table></table-wrap></table-wrap-group><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Participants’ knowledge of IPTp -SP (N = 120)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variable</th><th align="center" valign="middle" >N</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >Have you heard about IPTp</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >83</td><td align="center" valign="middle" >69.2</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >30.8</td></tr><tr><td align="center" valign="middle" >What is IPT-Sp?</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Taking of SP to prevent malaria in pregnancy</td><td align="center" valign="middle" >79</td><td align="center" valign="middle" >65.8</td></tr><tr><td align="center" valign="middle" >Taking of drugs when you are pregnant</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >23.4</td></tr><tr><td align="center" valign="middle" >Taking drug supplements</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >10.8</td></tr><tr><td align="center" valign="middle" >Who can be given IPTp-SP?</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Pregnant women</td><td align="center" valign="middle" >84</td><td align="center" valign="middle" >70.0</td></tr><tr><td align="center" valign="middle" >Infant</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >10.0</td></tr><tr><td align="center" valign="middle" >Aged people</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >12.5</td></tr><tr><td align="center" valign="middle" >Men</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >7.5</td></tr><tr><td align="center" valign="middle" >Drug of choice for IPTp</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Sulfadoxine Pyrimethamine (SP)</td><td align="center" valign="middle" >45</td><td align="center" valign="middle" >37.5</td></tr><tr><td align="center" valign="middle" >Artesunate single dose</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >20.0</td></tr><tr><td align="center" valign="middle" >Chloroquine</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >26.7</td></tr><tr><td align="center" valign="middle" >Quinine</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >15.8</td></tr><tr><td align="center" valign="middle" >Trimester for going for SP</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >First trimester (1st - 3rd months)</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >23.3</td></tr><tr><td align="center" valign="middle" >Second trimester (4th - 6th months)</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >46.7</td></tr><tr><td align="center" valign="middle" >Third trimester (7th - 9th months)</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >18.3</td></tr><tr><td align="center" valign="middle" >Don’t know</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >11.7</td></tr><tr><td align="center" valign="middle" >Is malaria a topic often discussed during ante-natal health talks?</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >74</td><td align="center" valign="middle" >61.7</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >46</td><td align="center" valign="middle" >38.3</td></tr><tr><td align="center" valign="middle" >Side effects of IPT</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Nausea</td><td align="center" valign="middle" >72</td><td align="center" valign="middle" >60.0</td></tr><tr><td align="center" valign="middle" >Vomiting</td><td align="center" valign="middle" >67</td><td align="center" valign="middle" >55.8</td></tr><tr><td align="center" valign="middle" >Dizziness</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >45.0</td></tr><tr><td align="center" valign="middle" >Bodily weakness</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >19.2</td></tr><tr><td align="center" valign="middle" >Don’t know</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >11.7</td></tr></tbody></table></table-wrap><table-wrap-group id="3"><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Barriers to the use of intermittent preventive strategies (N = 120)</title></caption><table-wrap id="3_1"><table><tbody><thead><tr><th align="center" valign="middle" >Variable</th><th align="center" valign="middle" >N</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >Possession of ITN</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >112</td><td align="center" valign="middle" >93.3</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >6.7</td></tr></tbody></table></table-wrap><table-wrap id="3_2"><table><tbody><thead><tr><th align="center" valign="middle" >Use of ITN</th><th align="center" valign="middle" ></th><th align="center" valign="middle" ></th></tr></thead><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >76</td><td align="center" valign="middle" >63.3</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >44</td><td align="center" valign="middle" >36.7</td></tr><tr><td align="center" valign="middle" >Reasons for not using mosquito nets during pregnancy</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Difficulty in setting up</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >26.7</td></tr><tr><td align="center" valign="middle" >Excessive heat generated under it</td><td align="center" valign="middle" >44</td><td align="center" valign="middle" >36.7</td></tr><tr><td align="center" valign="middle" >Preference for the use of mosquito coil</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >10.8</td></tr><tr><td align="center" valign="middle" >Uncomfortable to sleep in</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >22.5</td></tr><tr><td align="center" valign="middle" >Fear of getting sick from the drugs in the net</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >7.5</td></tr><tr><td align="center" valign="middle" >Reasons for not taking SP</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >I sleep under an ITN</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >46.7</td></tr><tr><td align="center" valign="middle" >I was not sick with malaria</td><td align="center" valign="middle" >67</td><td align="center" valign="middle" >55.8</td></tr><tr><td align="center" valign="middle" >The health unit is far</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >28.3</td></tr><tr><td align="center" valign="middle" >There no drugs at the ANC clinic</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >I feared side effects</td><td align="center" valign="middle" >45</td><td align="center" valign="middle" >37.5</td></tr><tr><td align="center" valign="middle" >I use herbs</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >10.0</td></tr><tr><td align="center" valign="middle" >I am not aware of the use of SP</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >7.5</td></tr><tr><td align="center" valign="middle" >Motivate you to correctly complete SP doses</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >When I am directly observed</td><td align="center" valign="middle" >97</td><td align="center" valign="middle" >80.8</td></tr><tr><td align="center" valign="middle" >Fewer dosage</td><td align="center" valign="middle" >109</td><td align="center" valign="middle" >90.8</td></tr><tr><td align="center" valign="middle" >When I am educated on drug and its usage</td><td align="center" valign="middle" >112</td><td align="center" valign="middle" >93.3</td></tr><tr><td align="center" valign="middle" >When I don’t have to walk distance to take it</td><td align="center" valign="middle" >78</td><td align="center" valign="middle" >65.0</td></tr><tr><td align="center" valign="middle" >A better taste of the drug</td><td align="center" valign="middle" >97</td><td align="center" valign="middle" >80.8</td></tr></tbody></table></table-wrap></table-wrap-group></sec></sec><sec id="s4"><title>4. Discussion</title><p>From the socio-demographic characteristics (<xref ref-type="table" rid="table1">Table 1</xref>), majority (52.5%) of the study participants reported for their first antenatal in their first trimester of pregnancy. This collaborates with findings from a similar study conducted in Tanzania by [<xref ref-type="bibr" rid="scirp.107945-ref11">11</xref>] where more than half of the study participants reported for antenatal clinic in their first trimester. Reporting late for Antenatal registration has been identified as a major cause of poor adherence to IPTp-SP regimen in pregnancy [<xref ref-type="bibr" rid="scirp.107945-ref12">12</xref>]. The ministry of health, Ghana, and Ghana health service launched a campaign as part of efforts to make primary healthcare accessible to all Ghanaians. As part of this campaign, The Community-based Health Planning and Services (CHPS) was introduced some fifteen years ago which reduced the burden of traveling long distances to access healthcare. This possibly could account for more than half of study participants reporting early for antenatal services.</p><p>Regarding the level of knowledge of respondents, more than half (69.2%) attested to having heard about IPTp-SP. This finding collaborates with findings from studies conducted in Sunyani-Ghana, Nigeria, and Tanzania [<xref ref-type="bibr" rid="scirp.107945-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.107945-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.107945-ref15">15</xref>] where majority of study participants knew about IPTp-SP. The high level of knowledge is also evident in <xref ref-type="table" rid="table2">Table 2</xref> where more than half of the participants (65.8%) understood that IPTp-SP included taking medication to prevent malaria, and 70% understood that the regimen was designed for pregnant women. However, only about 37.5% were able to identify the drug of choice for malaria prevention in pregnancy. This finding is consistent with findings from a study conducted by [<xref ref-type="bibr" rid="scirp.107945-ref16">16</xref>], where only 31.7% of respondent were able to identify the complete treatment plan involved in IPTp-SP. This phenomenon is again characterised in this present study where less than half (46.7%) of the respondents knew the appropriate time to commence malaria prophylaxis in pregnancy. Knowledge of antimalarial medications in Ghana is high possibly because of their availability over the counter and the ability of individuals to identify malaria symptoms without necessarily undergoing any diagnostic investigations as part of required standard practice.</p><p>From <xref ref-type="table" rid="table3">Table 3</xref>, majority (93.3%) of respondents had treated bedside mosquito nets at home. However, only 63.3% of respondents used these treated nets. This correlates with findings from a study conducted by [<xref ref-type="bibr" rid="scirp.107945-ref17">17</xref>] in Uganda where although about 84% of study participants possessed ITNs, only 66% of these participants use them regularly. With regards to possession, however, findings from both studies are encouraging as these findings exceed the expectation of the World Health organization which pegs possession at about 80% [<xref ref-type="bibr" rid="scirp.107945-ref18">18</xref>]. Some of the reasons identified by respondents as a cause of non-usage include difficulty in setting up, the heat generated under it, prefers to use mosquito coil, uncomfortable to sleep in, and fear of getting sick from the drugs in the net. These reasons were also found in similar studies in Ethiopia [<xref ref-type="bibr" rid="scirp.107945-ref19">19</xref>] and a trial in Kenya which assessed the reasons for non-usage of ITNs the previous night Kenya as part of an intervention program to enhance coverage [<xref ref-type="bibr" rid="scirp.107945-ref20">20</xref>]. In Ghana, insecticide-treated mosquito nets are often given to households at no cost as directed by the World Health Organization as part of efforts to eradicate malaria. This might explain why such many study participants have these nets at home.</p><p>Regarding the use of SP in pregnancy, this current study found distance to a health facility, not being sick with malaria, using herbs, already using ITN, and not being aware of SP as malaria prophylaxis. This finding is consistent with findings from a study conducted by [<xref ref-type="bibr" rid="scirp.107945-ref21">21</xref>] in northern Nigeria where non-adherent to SP regimen was identified among pregnant women. In both studies, however, majority of study participants preferred to take their chemoprophylaxis when they were directly observed. In its inception, the World Health Organization recommended that direct observation therapy should be implored to enhance wider coverage of SP usage by pregnant women [<xref ref-type="bibr" rid="scirp.107945-ref22">22</xref>]. For the women who were willing to take SP if doses were fewer, their assertion could boost a wide coverage and uptake of SP since most women in sub-Saharan Africa do not go for Antenatal visits until after the second trimester [<xref ref-type="bibr" rid="scirp.107945-ref23">23</xref>]. To achieve a wider coverage of preventing malaria in pregnancy, policymakers must target and streamline programmes that involve families and communities at large instead of limiting resources to pregnant women alone. As seen in <xref ref-type="table" rid="table2">Table 2</xref> and <xref ref-type="table" rid="table3">Table 3</xref>, majority of the women, although knew about malaria prevention, they still required a certain level of motivation to start or adhere to these preventive strategies. Contrary to findings from [<xref ref-type="bibr" rid="scirp.107945-ref24">24</xref>], which identified structural factors such as low medication stock and distance to health facilities as major challenges to the implementation of malaria prevention programs, findings from this present study found otherwise, with none of the respondents attributing poor compliance to non-availability of medications and supplies in health facilities.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Malaria in Pregnancy is a public health canker that adversely affects pregnant women, children, and their families in Sub-Saharan Africa. Knowledge of preventive strategies coupled with the availability of logistics is an important step in achieving a wider coverage of malaria prevention programs. Early antenatal visits and the motivation to frequently attend these visits are important to ensure that pregnant women receive complete doses of their chemoprophylaxis. Health education at antenatal clinics is also important to ensure that pregnant women are using their mosquito nets as required of them.</p></sec><sec id="s6"><title>6. Limitations</title><p>The study was conducted on specific antenatal days of the month and pregnant women who were not present were excluded from the study. Also, this survey utilized closed-ended questionnaires which did not make provision to explore the concept further as study participants limited their responses to specific questions.</p></sec><sec id="s7"><title>7. Future Directions</title><p>The researchers recommend that further studies should be conducted in multiple sites, including the communities to involve a larger group as well as to understand the variations of responses that may exist among diverse populations to inform policy and practice.</p></sec><sec id="s8"><title>Ethics</title><p>Ethical approval for the study was obtained from the Department of Nursing of the Presbyterian University College, Ghana, and the Management Board of the Juaben Government Hospital. Participation in the study was by choice, and codes were used to identify respondents instead of names. The process and purpose of the study were explained to respondents at the start of data collection. Participants were encouraged to opt-out at any time during the process when they wished to.</p></sec><sec id="s9"><title>Acknowledgements</title><p>We wish to acknowledge the efforts of our study participants for taking their time in answering the questionnaires. We also acknowledge the contribution of the staff and management of Juaben Government Hospital for their warm reception throughout this study.</p></sec><sec id="s10"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest in preparing and publishing this paper.</p></sec><sec id="s11"><title>Cite this paper</title><p>Agyei, F.B., Dzando, G., Donyi, A.B., Nonoh, E.A., Dordunu, R. and Opoku, C.K. (2021) Knowledge and Perceived Barriers towards Intermittent Prevention of Malaria in Pregnancy: A Cross-Sectional Study. Open Journal of Internal Medicine, 11, 27-38. https://doi.org/10.4236/ojim.2021.111002</p></sec></body><back><ref-list><title>References</title><ref id="scirp.107945-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">WHO (2016) World Malaria Report. World Health Organization, Geneva.</mixed-citation></ref><ref id="scirp.107945-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Diala, C.C., Pennas, T., Marin, C. and Belay, K.A. (2013) Perceptions of Intermittent Preventive Treatment of Malaria in Pregnancy (IPTp) and Barriers to Adherence in Nasarawa and Cross River States in Nigeria. Malaria Journal, 12, 342.  
https://doi.org/10.1186/1475-2875-12-342</mixed-citation></ref><ref id="scirp.107945-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Hill, J., Hoyt, J., van Eijk, A.M., D’Mello-Guyett, L., Ter Kuile, F.O., Steketee, R., Webster, J., et al. (2013) Factors Affecting the Delivery, Access, and Use of Interventions to Prevent Malaria in Pregnancy in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. PLOS Medicine, 10, e1001488.  
https://doi.org/10.1371/journal.pmed.1001488</mixed-citation></ref><ref id="scirp.107945-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Global Malaria Programme, W.H.O. (2012) World Malaria Report 2012.</mixed-citation></ref><ref id="scirp.107945-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Iliyasu, Z., Gajida, A.U., Galadanci, H.S., Abubakar, I.S., Baba, A.S., Jibo, A.M. and Aliyu, M.H. (2012) Adherence to Intermittent Preventive Treatment for Malaria in Pregnancy in Urban Kano, Northern Nigeria. Pathogens and Global Health, 106, 323-329. https://doi.org/10.1179/2047773212Y.0000000037</mixed-citation></ref><ref id="scirp.107945-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Alaii, J.A., Hawley, W.A., Kolczak, M.S., Ter Kuile, F.O., Gimnig, J.E., Vulule, J.M., Phillips-Howard, P.A., et al. (2003) Factors Affecting Use of Permethrin-Treated Bed Nets during a Randomized Controlled Trial in Western Kenya. The American Journal of Tropical Medicine and Hygiene, 68, 137-141.  
https://doi.org/10.4269/ajtmh.2003.68.137</mixed-citation></ref><ref id="scirp.107945-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Baume, C.A., Reithinger, R. and Woldehanna, S. (2009) Factors Associated with Use and Non-Use of Mosquito Nets Owned in Oromia and Amhara Regional States, Ethiopia. Malaria Journal, 8, 264. https://doi.org/10.1186/1475-2875-8-264</mixed-citation></ref><ref id="scirp.107945-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">WHO (2007) Insecticide-Treated Mosquito Nets: WHO Position Statement.  
http://www.ivcc.com/sites/ivcc.mrmdev.co.uk/files/content/itnspospaperfinal.pdf</mixed-citation></ref><ref id="scirp.107945-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Taremwa, I.M., Ashaba, S., Adrama, H.O., Ayebazibwe, C., Omoding, D., Kemeza, I., Hilliard, R., et al. (2017) Knowledge, Attitude and Behaviour towards the Use of Insecticide Treated Mosquito Nets among Pregnant Women and Children in Rural Southwestern Uganda. BMC Public Health, 17, 794.  
https://doi.org/10.1186/s12889-017-4824-4</mixed-citation></ref><ref id="scirp.107945-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Obieche, A.O., Enato, E.F. and Ande, A.B. (2015) Assessment of Knowledge, Interventional Practices for, and Impact of Malaria in Pregnancy among Parturient Women in a Nigerian Tertiary Healthcare Facility. Tropical Journal of Pharmaceutical Research, 14, 1103-1110. https://doi.org/10.4314/tjpr.v14i6.24</mixed-citation></ref><ref id="scirp.107945-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Exavery, A., Mbaruku, G., Mbuyita, S., Makemba, A., Kinyonge, I.P. and Kweka, H. (2014) Factors Affecting Uptake of Optimal Doses of Sulphadoxine-Pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in Six Districts of Tanzania. Malaria Journal, 13, 22. https://doi.org/10.1186/1475-2875-13-22</mixed-citation></ref><ref id="scirp.107945-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Amoran, O.E., Ariba, A.A. and Iyaniwura, C.A. (2012) Determinants of Intermittent Preventive Treatment of Malaria during Pregnancy (IPTp) Utilization in a Rural Town in Western Nigeria. Reproductive Health, 9, Article No. 12.  
https://doi.org/10.1186/1742-4755-9-12</mixed-citation></ref><ref id="scirp.107945-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Ibrahim, H., Maya, E.T., Issah, K., Apanga, P.A., Bachan, E.G. and Noora, C.L. (2017) Factors Influencing Uptake of Intermittent Preventive Treatment of Malaria in Pregnancy Using Sulphadoxine Pyrimethamine in Sunyani Municipality, Ghana. The Pan African Medical Journal, 28, 122.  
https://doi.org/10.11604/pamj.2017.28.122.12611</mixed-citation></ref><ref id="scirp.107945-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Oyibo, W.A. and Agomo, C.O. (2011) Scaling Up of Intermittent Preventive Treatment of Malaria in Pregnancy Using Sulphadoxine-Pyrimethamine: Prospects and Challenges. Maternal and Child Health Journal, 15, 542-552.  
https://doi.org/10.1007/s10995-010-0608-5</mixed-citation></ref><ref id="scirp.107945-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Anders, K., Marchant, T., Chambo, P., Mapunda, P. and Reyburn, H. (2008) Timing of Intermittent Preventive Treatment for Malaria during Pregnancy and Implications of Current Policy on Early Up Take in North-East Tanzania. Malaria Journal, 7, 79. https://doi.org/10.1186/1475-2875-7-79</mixed-citation></ref><ref id="scirp.107945-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Krejcie, R.V. and Morgan, D.W. (1970) Determining Sample Size for Research Activities. Educational and Psychological Measurement, 30, 607-610.  
https://doi.org/10.1177/001316447003000308</mixed-citation></ref><ref id="scirp.107945-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Fokam, E.B., Ngimuh, L., Anchang-Kimbi, J.K. and Wanji, S. (2016) Assessment of the Usage and Effectiveness of Intermittent Preventive Treatment and Insecticide-Treated Nets on the Indicators of Malaria among Pregnant Women Attending Antenatal Care in the Buea Health District, Cameroon. Malaria Journal, 15, 172.  
https://doi.org/10.1186/s12936-016-1228-3</mixed-citation></ref><ref id="scirp.107945-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Global Malaria Programme: Pregnant Women and Infants. World Health Organization. http://apps.who.int/malaria/pregnantwomenand infants.html</mixed-citation></ref><ref id="scirp.107945-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">WHO (2004) A Strategic Framework for Malaria Prevention and Control during Pregnancy in the Africa Region. World Health Organization Regional Office for Africa, Geneva, AFR/MAL/04/01.</mixed-citation></ref><ref id="scirp.107945-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Awine, T., Malm, K., Bart-Plange, C. and Silal, S.P. (2017) Towards Malaria Control and Elimination in Ghana: Challenges and Decision-Making Tools to Guide Planning. Global Health Action, 10, Article ID: 1381471.  
https://doi.org/10.1080/16549716.2017.1381471</mixed-citation></ref><ref id="scirp.107945-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Fried, M. and Duffy, P.E. (2017) Malaria during Pregnancy. Cold Spring Harbor Perspectives in Medicine, 7, a025551. https://doi.org/10.1101/cshperspect.a025551</mixed-citation></ref><ref id="scirp.107945-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Park, S., Nixon, C.E., Miller, O., Choi, N.K., Kurtis, J.D., Friedman, J.F. and Michelow, I.C. (2020) Impact of Malaria in Pregnancy on Risk of Malaria in Young Children: Systematic Review and Meta-Analyses. The Journal of Infectious Diseases, 222, 538-550. https://doi.org/10.1093/infdis/jiaa139</mixed-citation></ref><ref id="scirp.107945-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">WHO (2018) World Malaria Report 2018. World Health Organization, Geneva.  
https://www.who.int/malaria/publications/world-malaria-report-2018/en</mixed-citation></ref><ref id="scirp.107945-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Lawn, J.E., Blencowe, H., Waiswa, P., Amouzou, A., Mathers, C., Hogan, D., Draper, E.S., et al. (2016) Stillbirths: Rates, Risk Factors, and Acceleration towards 2030. The Lancet, 387, 587-603. https://doi.org/10.1016/S0140-6736(15)00837-5</mixed-citation></ref></ref-list></back></article>